Eversept Partners’s Korsana Biosciences KRSA Stock Holding History
Bought
Maintained
Sold
Other funds holding KRSA
MP
AG
Eversept Partners's KRSA Position: Q2 2022 in Review
Eversept Partners sold out of Korsana Biosciences (KRSA) in Q2 2022, closing a stake of 2,657 shares — an estimated $413K sold.
Eversept Partners first reported a position in KRSA in Q2 2019 and held it in 6 quarters. The position peaked at $1.46M in Q2 2020. 36 funds tracked by Wall St. Rank hold KRSA as of Q2 2022.
- Eversept Partners reported no remaining Korsana Biosciences position as of Q2 2022 after selling out during the quarter.
- Eversept Partners sold 2,657 Korsana Biosciences shares in Q2 2022, an estimated $413K.
- Eversept Partners first reported a position in Korsana Biosciences in Q2 2019 and held it in 6 quarters.
- Eversept Partners's Korsana Biosciences position peaked at $1.46M in Q2 2020.
- 36 funds tracked by Wall St. Rank held Korsana Biosciences as of Q2 2022.
Based on Eversept Partners's 13F filing for Q2 2022, filed 15 Aug 2022.